Nucleic Acids Research, 1992, Vol. 20, No. 23 6287-6295
© 1992
MOLECULAR BIOLOGY |
A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins
GenPharm International 2375 Garcia Avenue, Mountain View, CA 94043, USA
*To whom correspondence should be addressed
Received August 27, 1992. Revised October 26, 1992. Accepted October 26, 1992.
We have generated transgenic mice that express a diverse repertoire of human sequence immunoglobulins. The expression of this repertoire is directed by light and heavy chain minilocus transgenes comprised of human protein coding sequences in an unrearranged, germ-line configuration. In this paper we describe the construction of these miniloci and the composition of the CDR3 repertoire generated by the transgenic mice. The largest transgene discussed is a heavy chain minilocus that includes human µand
1 coding sequences together with their respective switch regions. It consists of a single 61 kb DNA fragment propagated in a bacterial plasmid vector. Both human heavy chain classes are expressed in animals that carry the transgene. In light chain transgenic animals the unrearranged minilocus sequences recombine to form VJ joints that use all five human Jx, segments, resulting in a diversity of human-like CDR3 regions. Similarly, in heavy chain transgenics the inserted sequences undergo VDJ joining complete with N region addition to generate a human-like VH CDR3 repertoire. All six human JH segments and at least eight of the ten transgene encoded human D segments are expressed. The transgenic animals described in this paper represent a potential source of human sequence antibodies for in vivo therapeutic applications.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Tzipori, A. Sheoran, D. Akiyoshi, A. Donohue-Rolfe, and H. Trachtman Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome Clin. Microbiol. Rev., October 1, 2004; 17(4): 926 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Skov, K. Kragballe, C. Zachariae, E. R. Obitz, E. A. Holm, G. B. E. Jemec, H. Solvsten, H. H. Ibsen, L. Knudsen, P. Jensen, et al. HuMax-CD4: A Fully Human Monoclonal Anti-CD4 Antibody for the Treatment of Psoriasis Vulgaris Arch Dermatol, November 1, 2003; 139(11): 1433 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, R. E. Hammer, J. B. George-Raizen, K. C. Meyers, and W. T. Garrard High-Level Rearrangement and Transcription of Yeast Artificial Chromosome-Based Mouse Ig{kappa} Transgenes Containing Distal Regions of the Contig J. Immunol., January 15, 2000; 164(2): 812 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Ball Jr., R. Kasturi, P. Dey, M. Tabet, S. O'Donnell, D. Hudson, and D. Fishwild Isolation and Characterization of Human Monoclonal Antibodies to Digoxin J. Immunol., August 15, 1999; 163(4): 2291 - 2298. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tuaillon and J. D. Capra Use of D gene segments with irregular spacers in terminal deoxynucleotidyltransferase (TdT)+/+ and TdT-/- mice carrying a human Ig heavy chain transgenic minilocus PNAS, February 17, 1998; 95(4): 1703 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zou, H Gu, and K Rajewsky Generation of a mouse strain that produces immunoglobulin kappa chains with human constant regions Science, November 19, 1993; 262(5137): 1271 - 1274. [Abstract] [PDF] |
||||




